Yeji
FDA approvaloutcome: successconf 1.00

betaine anhydrous — FDA approval

$ETON · Eton Pharmaceuticals, Inc.
Event date
January 28, 2022
1590 days ago
Sponsor runway
cash-flow +
$19.7M liquid

Evidence

openFDA ORIG (UNKNOWN) approval of BETAINE ANHYDROUS — application ANDA210508

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

7 insiders · 0 buys · 13 sells
Grant
2022-02-07
CASAMENTO CHARLES J
Director
50,000 @
Grant
2022-02-07
Adams Jennifer McKie
Director
50,000 @
Grant
2022-02-07
MAIER PAUL V
Director
50,000 @
Grant
2022-02-07
BRYNJELSEN SEAN
President & CEO
416,500 @
Grant
2022-02-07
Troutman William Wilson
CFO and Secretary
15,000 @
Grant
2022-02-07
RIEDEL NORBERT G
Director
50,000 @
Sell
2021-11-17
Opaleye Management Inc.
10%+ Owner
25,000 @ $4.67$117K
Sell
2021-11-16
Opaleye Management Inc.
10%+ Owner
938 @ $4.86$5K
Sell
2021-11-16
Opaleye Management Inc.
10%+ Owner
11,500 @ $4.86$56K
Sell
2021-11-15
Opaleye Management Inc.
10%+ Owner
500 @ $4.80$2K
Sell
2021-11-15
Opaleye Management Inc.
10%+ Owner
2,500 @ $4.80$12K
Sell
2021-11-08
Opaleye Management Inc.
10%+ Owner
50,000 @ $6.10$305K
Sell
2021-11-08
Opaleye Management Inc.
10%+ Owner
2,661 @ $6.10$16K
Sell
2021-11-05
Opaleye Management Inc.
10%+ Owner
8,401 @ $6.30$53K
Sell
2021-11-05
Opaleye Management Inc.
10%+ Owner
159,300 @ $6.30$1.00M
Sell
2021-11-04
Opaleye Management Inc.
10%+ Owner
81,700 @ $6.44$526K
Sell
2021-11-04
Opaleye Management Inc.
10%+ Owner
4,000 @ $6.44$26K
Sell
2021-11-03
Opaleye Management Inc.
10%+ Owner
110,000 @ $6.53$718K
Sell
2021-11-03
Opaleye Management Inc.
10%+ Owner
6,500 @ $6.53$42K